Behavioural Effects and Naloxone Effectiveness With New Synthetic Opioids

Datos Bibliográficos

ID21596830
AutoresSuzanne Nielsen (0000-0001-5341-1055, Monash Addiction Research Centre, Eastern Health Clinical School Monash University Melbourne Australia, autor de correspondencia), João Pedro Silva (0000-0002-5656-0897, UCIBIO ‐ Applied Molecular Biosciences Unit/i4HB ‐ Associate Laboratory Institute for Health and Bioeconomy, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy University of Porto Porto Portugal), Jermaine D Jones (0000-0003-4476-2800, Division on Substance Use Disorders Columbia University Irving Medical Center & New York State Psychiatric Institute New York USA), Alex J Krotulski (0000-0003-1775-1882, Center for Forensic Science Research and Education, Fredric Rieders Family Foundation Horsham USA), Dilkushi Poovendran (0000-0002-9919-2932, Department of Health Product Policies and Standards World Health Organization Geneva Switzerland), Deusdedit Muzangizi (Department of Health Product Policies and Standards World Health Organization Geneva Switzerland), Gilles Forte (Division of Access to Medicines and Health Products World Health Organization Geneva Switzerland), Jason White (0000-0003-1918-4789, Clinical and Health Sciences, University of South Australia Adelaide Australia), Jason M White (0000-0001-6750-1078, University of South Australia), SANDRA D COMER (0000-0002-8166-548X, Division on Substance Use Disorders Columbia University Irving Medical Center & New York State Psychiatric Institute New York USA)
Año2026
Volumen45
Número1
Páginase70040-e70040
Fecha de publicación2026-01-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaDrug and Alcohol Review (JOURNAL)
Identificadores de la revistaISSN: 0959-5236 • E-ISSN: 1465-3362
EditorialWiley (PUBLISHER • GB)
DOI10.1111/dar.70040
PMID41093771
OpenAlexW4415268733
IdiomaEN
Referencias citadas57